Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2000
08/09/2000EP1025849A1 Methods for detection and treatment of individuals having abnormal cells expressing HLA-A2/tyrosinase peptide antigens
08/09/2000EP1025434A1 A multichannel microscale system for high throughput preparative separation with comprehensive collection and analysis
08/09/2000EP1025265A1 Methods for detecting contamination in molecular diagnostics using pcr
08/09/2000EP1025262A1 Screening for novel bioactivities
08/09/2000EP1025261A1 Compositions and methods for determining predisposition to insulin dependent diabetes mellitus
08/09/2000EP1025253A1 Positive-negative selection for homologous recombination
08/09/2000EP1025252A1 Efficient construction of gene targeting vectors
08/09/2000EP1025251A1 Amplifiable adeno-associated virus (aav) packaging cassettes for the production of recombinant aav vectors
08/09/2000EP1025250A2 Modification of the tocopherol content of transgenic plants
08/09/2000EP1025249A1 Novel seed specific promoters based on plant genes
08/09/2000EP1025248A1 Reduction of chlorophyll content in oil plant seeds
08/09/2000EP1025247A1 In planta method for the production of transgenic plants
08/09/2000EP1025246A1 Methods for identifying nucleic acid sequences and (poly)peptides which increase the expression yields of functional periplasmic proteins
08/09/2000EP1025245A2 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
08/09/2000EP1025244A2 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
08/09/2000EP1025243A2 TRANSCRIPTIONALLY-ACTIVATED AAV INVERTED TERMINAL REPEATS (ITRs) FOR USE WITH RECOMBINANT AAV VECTORS
08/09/2000EP1025242A1 A method of inhibiting an immune response to a recombinant vector
08/09/2000EP1025241A2 Multiply-substituted protease variants
08/09/2000EP1025240A2 Multiply-substituted protease variants with altered net charge for use in detergents
08/09/2000EP1025239A2 Multiply-substituted protease variants
08/09/2000EP1025238A2 Death associated kinase containing ankyrin repeats (dakar)
08/09/2000EP1025237A2 Human checkpoint kinase, hcds1, compositions and methods
08/09/2000EP1025236A2 Human checkpoint kinase, hcds1, compositions and methods
08/09/2000EP1025235A1 Expression system
08/09/2000EP1025234A1 Binary viral expression system in plants
08/09/2000EP1025233A2 Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems
08/09/2000EP1025232A1 A novel mitogenic cyclin and uses thereof
08/09/2000EP1025231A1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance
08/09/2000EP1025230A2 ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE
08/09/2000EP1025229A1 Chemokines with amino-terminal modifications
08/09/2000EP1025228A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2
08/09/2000EP1025227A2 Human toll homologues
08/09/2000EP1025226A1 Dna encoding a human proton-gated ion channel and uses thereof
08/09/2000EP1025225A1 P-40/annexin i and related proteins and their role in multidrug resistance
08/09/2000EP1025224A1 Human nip-45: interleukin-4 gene transcriptional trans-activator and its uses
08/09/2000EP1025223A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
08/09/2000EP1025222A1 Genetic and protein therapy products for treating cystic fibrosis and inducing a glutathione-s-transferase function
08/09/2000EP1025221A2 ErbB-4 TARGETED RIBOZYMES
08/09/2000EP1025220A1 JMY, A CO-ACTIVATOR FOR p300/CBP, NUCLEIC ACID ENCODING JMY AND USES THEREOF
08/09/2000EP1025219A2 Antisense oligonucleotide sequences as inhibitors of microorganisms
08/09/2000EP1025218A1 Method to screen phage display libraries with different ligands
08/09/2000EP1025217A1 Recombinational cloning using nucleic acids having recombination sites
08/09/2000EP1025216A1 Transgenic animal models for cardiac hypertrophy and uses thereof
08/09/2000EP1025215A2 Plant phosphatases
08/09/2000EP1025213A1 Epoxide hydrolase
08/09/2000EP1025212A2 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
08/09/2000EP1025211A2 Hyaluronan synthase gene and uses thereof
08/09/2000EP1025210A2 Plant branched-chain amino acid biosynthetic enzymes
08/09/2000EP1025208A2 A packaging cell line producing siv-pseudotyped mlv
08/09/2000EP1025207A1 Suspension packing cell lines for retrovirus vectors
08/09/2000EP1025206A1 Cell lines useful for (in vitro) assay for identification of carcinogens
08/09/2000EP1025205A2 (in vitro) differentiation of vascular smooth muscle cells, methods and reagents related thereto
08/09/2000EP1025204A1 Methods and materials for the growth of primate-derived primordial stem cells
08/09/2000EP1025203A1 Impaired brca2 function in cells and non-human transgenic animals
08/09/2000EP1025194A1 Bleaching compositions comprising multiply-substituted protease variants
08/09/2000EP1025129A1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan
08/09/2000EP1025124A1 Low-toxicity human interferon-alpha analogues
08/09/2000EP1025122A1 Fibroblast growth factor with hepatocyte proliferation activity
08/09/2000EP1025121A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE $g(b)-AMYLOID PEPTIDE OR ITS PRECURSOR
08/09/2000EP1025113A1 Improved process for performing polynucleotide separations
08/09/2000EP1024836A1 Method of delivering genes to antigen presenting cells of the skin
08/09/2000EP1024828A1 NOVEL pheS (BETA)
08/09/2000EP1024827A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
08/09/2000EP1024825A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity
08/09/2000EP1024822A1 Cd8 as an inhibitor of the cellular immune system
08/09/2000EP1024821A1 Novel prokaryotic polynucleotides, polypeptides and their uses
08/09/2000EP1024809A1 Use of immunomodulating agents
08/09/2000EP1024701A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
08/09/2000EP0868119A4 Conditionally male-fertile plants and methods and compositions for restoring the fertility thereof
08/09/2000EP0690914B1 Allergenic protein and peptides from house dust mite and uses therefor
08/09/2000EP0663010B1 Methods for increasing secretion of overexpressed proteins
08/09/2000EP0640133B1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
08/09/2000EP0629238B1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
08/09/2000EP0568645B1 Mixed specificity fusion proteins
08/09/2000EP0556171B1 Growth hormone antagonists
08/09/2000EP0533846B1 The ciliary neurotrophic factor receptor
08/09/2000CN1262690A Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of same
08/09/2000CN1262689A Isolated dendritic cell membrane protein genes
08/09/2000CN1262687A Eukaryotic and retroviral antisense initiator elements
08/09/2000CN1262328A Expression function of vascular bundle for specifically expressing different sigments of promotor profilin 2
08/09/2000CN1262326A Transgenosis plant containing vergence soy-bean isodynamic calcium modulated protein gene for resisting multiple diseases
08/09/2000CN1262323A High-pressure gas gene gun
08/09/2000CN1262032A Animal ceratin transgenic cotton fibre and its gene engineering method
08/09/2000CN1055314C Cloning and over expression of glucose-6-phosphate dehydrogenase fro leuconostoc dextranicus
08/09/2000CN1055313C Recombinative plasmid for high-efficient expressing HBsAg in cell of mammal
08/09/2000CN1055312C Method for preparation of human interleukin-6 and its products
08/09/2000CA2327264A1 Polypeptide having antihuman immunodeficiency virus activity, gene encoding the polypeptide and process for producing the polypeptide
08/08/2000US6100456 Lepidopteran insect resistant transgenic potato plants
08/08/2000US6100453 Genetically engineering plants against infection; transforming pear cultivars with a gene which encodes for a lytic protein, recovering hybrid pears which lack sensitivity to plant disease
08/08/2000US6100451 Nucleic acid sequences associated with transcriptional control in plants; for the development of disease resistance plants
08/08/2000US6100450 Nucleotide sequences associated with heterologous gene expression in plants
08/08/2000US6100449 Nucleotide sequences which code protein which prevents or reduces fungal infection
08/08/2000US6100448 Increasing expression of transgenes in plant cells using insulator elements
08/08/2000US6100447 Method of barley transformation
08/08/2000US6100446 Plant cell transformed with nucleotide sequences which code a degratory enzymatic protein; for pollution control
08/08/2000US6100445 Hybrid rodent with homogeneity for cytokine mutation; for prevention of apoptosis; antiproliferative agents
08/08/2000US6100444 Nucleotide sequences coding prostate gland protein; for the treatment of prostate cancer
08/08/2000US6100443 Universal donor cells
08/08/2000US6100390 Nucleotide sequences coding nematode protein; for the prevention of nematode infection of animals
08/08/2000US6100389 Nucleotide sequences coding protein: for stem cell mobilization, myloid and neuronal cell protection; for the treatment and prevention of tumors and parasitic infection; wound healing agents; antitumor agents